Adia Nutrition, Inc. Reports Strong Revenue Growth in 2025 Annual Report, Highlights Transition to Regenerative Medicine and Full SEC Reporting Status
Winter Park, Florida–(Newsfile Corp. – April 1, 2026) – Adia Nutrition, Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapy, and premium wellness solutions, today announced key highlights from its annual Form 10-K report for the year ended December 31, 2025. a dormant shell to an active player in the high-growth regenerative health … Read more
